US Stock MarketDetailed Quotes

TSBX Turnstone Biologics

Watchlist
  • 2.710
  • +0.110+4.23%
Close May 28 16:00 ET
  • 2.670
  • -0.040-1.48%
Post 17:42 ET
62.68MMarket Cap-836P/E (TTM)

Turnstone Biologics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
0
-73.66%19.31M
0
0
0
80.13%19.31M
-27.64%73.3M
10.45M
10.22M
41.92M
Operating revenue
--0
-73.66%19.31M
--0
--0
--0
80.13%19.31M
-27.64%73.3M
--10.45M
--10.22M
--41.92M
Cost of revenue
Gross profit
Operating expense
5.03%20.69M
-25.34%78.34M
-27.32%17.86M
-28.54%18.93M
-28.28%21.85M
-15.81%19.7M
53.63%104.93M
24.57M
26.49M
30.47M
Selling and administrative expenses
21.55%4.9M
-2.06%17.85M
1.03%4.4M
-9.20%4.76M
18.49%4.66M
-14.18%4.03M
34.53%18.22M
--4.35M
--5.24M
--3.93M
-General and administrative expense
21.55%4.9M
-2.06%17.85M
1.03%4.4M
-9.20%4.76M
18.49%4.66M
-14.18%4.03M
34.53%18.22M
--4.35M
--5.24M
--3.93M
Research and development costs
0.78%15.79M
-30.23%60.49M
-33.42%13.46M
-33.31%14.17M
-35.21%17.19M
-16.22%15.67M
58.35%86.7M
--20.21M
--21.25M
--26.54M
Operating profit
-5,151.52%-20.69M
-86.66%-59.03M
-26.46%-17.86M
-16.34%-18.93M
-290.91%-21.85M
96.89%-394K
-195.86%-31.63M
-14.12M
-16.27M
11.45M
Net non-operating interest income expense
Other net income (expense)
183.68%1.08M
280.06%3.55M
165.17%1.24M
689.00%1.58M
92.78%347K
347.06%380K
31.78%933K
468K
200K
180K
Other non- operating income (expenses)
183.68%1.08M
280.06%3.55M
165.17%1.24M
689.00%1.58M
92.78%347K
347.06%380K
31.78%933K
--468K
--200K
--180K
Income before tax
-139,992.86%-19.61M
-80.78%-55.49M
-21.70%-16.62M
-7.97%-17.35M
-284.97%-21.51M
99.89%-14K
-191.07%-30.69M
-13.65M
-16.07M
11.63M
Income tax
119.51%16K
-302.84%-286K
-1,200.00%-165K
-141.25%-33K
-123.08%-6K
-510.00%-82K
-67.36%141K
15K
80K
26K
Net income
-28,966.18%-19.63M
-79.02%-55.2M
-20.36%-16.45M
-7.23%-17.32M
-285.34%-21.5M
100.54%68K
-192.68%-30.83M
-13.67M
-16.15M
11.6M
Net income continuous Operations
-28,966.18%-19.63M
-79.02%-55.2M
-20.36%-16.45M
-7.23%-17.32M
-285.34%-21.5M
100.54%68K
-192.68%-30.83M
---13.67M
---16.15M
--11.6M
Minority interest income
Net income attributable to the parent company
-28,966.18%-19.63M
-79.02%-55.2M
-20.36%-16.45M
-7.23%-17.32M
-285.34%-21.5M
100.54%68K
-192.68%-30.83M
-13.67M
-16.15M
11.6M
Preferred stock dividends
Other preferred stock dividends
0
68K
Net income attributable to common stockholders
-19.63M
-79.02%-55.2M
-20.36%-16.45M
-7.23%-17.32M
-285.34%-21.5M
0
-192.68%-30.83M
-13.67M
-16.15M
11.6M
Basic earnings per share
-0.85
-243.98%-4.78
-18.52%-0.73
-37.38%-1
-285.34%-0.9689
0
-192.68%-1.3896
-0.6159
-0.7279
0.5228
Diluted earnings per share
-0.85
-243.98%-4.78
-18.52%-0.73
-37.38%-1
-285.34%-0.9689
0
-192.68%-1.3896
-0.6159
-0.7279
0.5228
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 0-73.66%19.31M00080.13%19.31M-27.64%73.3M10.45M10.22M41.92M
Operating revenue --0-73.66%19.31M--0--0--080.13%19.31M-27.64%73.3M--10.45M--10.22M--41.92M
Cost of revenue
Gross profit
Operating expense 5.03%20.69M-25.34%78.34M-27.32%17.86M-28.54%18.93M-28.28%21.85M-15.81%19.7M53.63%104.93M24.57M26.49M30.47M
Selling and administrative expenses 21.55%4.9M-2.06%17.85M1.03%4.4M-9.20%4.76M18.49%4.66M-14.18%4.03M34.53%18.22M--4.35M--5.24M--3.93M
-General and administrative expense 21.55%4.9M-2.06%17.85M1.03%4.4M-9.20%4.76M18.49%4.66M-14.18%4.03M34.53%18.22M--4.35M--5.24M--3.93M
Research and development costs 0.78%15.79M-30.23%60.49M-33.42%13.46M-33.31%14.17M-35.21%17.19M-16.22%15.67M58.35%86.7M--20.21M--21.25M--26.54M
Operating profit -5,151.52%-20.69M-86.66%-59.03M-26.46%-17.86M-16.34%-18.93M-290.91%-21.85M96.89%-394K-195.86%-31.63M-14.12M-16.27M11.45M
Net non-operating interest income expense
Other net income (expense) 183.68%1.08M280.06%3.55M165.17%1.24M689.00%1.58M92.78%347K347.06%380K31.78%933K468K200K180K
Other non- operating income (expenses) 183.68%1.08M280.06%3.55M165.17%1.24M689.00%1.58M92.78%347K347.06%380K31.78%933K--468K--200K--180K
Income before tax -139,992.86%-19.61M-80.78%-55.49M-21.70%-16.62M-7.97%-17.35M-284.97%-21.51M99.89%-14K-191.07%-30.69M-13.65M-16.07M11.63M
Income tax 119.51%16K-302.84%-286K-1,200.00%-165K-141.25%-33K-123.08%-6K-510.00%-82K-67.36%141K15K80K26K
Net income -28,966.18%-19.63M-79.02%-55.2M-20.36%-16.45M-7.23%-17.32M-285.34%-21.5M100.54%68K-192.68%-30.83M-13.67M-16.15M11.6M
Net income continuous Operations -28,966.18%-19.63M-79.02%-55.2M-20.36%-16.45M-7.23%-17.32M-285.34%-21.5M100.54%68K-192.68%-30.83M---13.67M---16.15M--11.6M
Minority interest income
Net income attributable to the parent company -28,966.18%-19.63M-79.02%-55.2M-20.36%-16.45M-7.23%-17.32M-285.34%-21.5M100.54%68K-192.68%-30.83M-13.67M-16.15M11.6M
Preferred stock dividends
Other preferred stock dividends 068K
Net income attributable to common stockholders -19.63M-79.02%-55.2M-20.36%-16.45M-7.23%-17.32M-285.34%-21.5M0-192.68%-30.83M-13.67M-16.15M11.6M
Basic earnings per share -0.85-243.98%-4.78-18.52%-0.73-37.38%-1-285.34%-0.96890-192.68%-1.3896-0.6159-0.72790.5228
Diluted earnings per share -0.85-243.98%-4.78-18.52%-0.73-37.38%-1-285.34%-0.96890-192.68%-1.3896-0.6159-0.72790.5228
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion with Explanatory Notes------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg